Abstract
Work Productivity Loss And Indirect Costs Associated With New Cardiovascular Events In High-Risk Patients With Hyperlipidemia - Estimates From Population-Based Register Data In Sweden
Highlights
The lowest incremental cost-effectiveness ratios (ICER) were obtained with the EuroQol-5 dimension (EQ-5D) but this may not capture side-effects picked up by the cancer-specific utility measures
The aim of the study was to assess the comparative efficacy of recommended treatment for chronic heart failure with reduced ejection fraction in terms of all-cause mortality based on a network met-analysis (NMA) of randomized controlled trials (RCTs) and to explore the impact of alternative treatment classifications depending on concomitant treatments
Using the 2010 Dutch Hospital Data (DHD), we identified all patients admitted to hospital with Acute heart failure (AHF) as a primary diagnosis
Summary
To assess the impact of different levels of clinical pharmacy intervention (CPI) on therapeutic plan and cost saving through monitoring and follow-up of some medications (including 20% Human Albumin, Meropenem and Cefepime) over three separated months. Regarding Cefepime, both PCPI and ECPI reduced the dispensed quantity, interestingly PCPI saved more than ECPI (25% and 4.58% respectively) This could be due to the clinical pharmacist recommendation according to local antibiogram. Costello Medical Consulting Ltd., Cambridge, UK Objectives: To ascertain whether disease prevalence alone explains elective and non-elective patient admission rates, general practitioner (GP) referral rates and prescribing spends in 20 North London Clinical Commissioning Groups (CCGs). Results: Of the 20 North London CCGs included in this analysis, 4 reported a higher non-elective admission rate (per 1,000 of the population) than the national average. Conclusions: Disease prevalence appears to explain rates of elective admissions and GP referrals relatively well in North London CCGs compared to non-elective admission rates. Non-elective admissions commonly occur in emergency situations, making
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
